Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

WWARN's Head of Drug Quality, Professor Paul Newton, published important research findings in the British Medical Journal this week.

The paper, developed by Prof Newton and colleagues at the London School of Hygiene & Tropical Medicine and the Liverpool School of Tropical Medicine, reviews the quality of medicines used in clinical trials, and suggests that tighter guidelines are needed to ensure that drugs are carefully monitored for overall quality, deterioration and evidence of counterfeit or substandard medicines enterring the distribution chain.

Read more (WorldWide Antimalarial Resistance Network (WWARN) website)